Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3538)
All Articles published online
|
Publishing Process of This Article
|
Dec 25, 2024 (publication date) through Nov 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Stepanova N. Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials. World J Nephrol 2024; 13(4): 98719 [PMID: 39723354 DOI: 10.5527/wjn.v13.i4.98719] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Stepanova N. Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials. World J Nephrol 2024; 13(4): 98719 [PMID: 39723354 DOI: 10.5527/wjn.v13.i4.98719] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i4/98719.htm |
| Number | Citing Articles |
| 1 |
Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao. Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine 2025; 148: 157496 doi: 10.1016/j.phymed.2025.157496
|
| 2 |
Mengqi Wu, Xin Zhou, Saiping Chen, Yuqing Wang, Bin Lu, Aiping Zhang, Yanqin Zhu, Min Huang, Jiarui Wang, Junyi Liu, Fenggui Zhu, Hong Liu, Riyang Lin. The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1606700
|
| 3 |
Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai. Fecal microbiota transplantation is a promising therapy for kidney diseases. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1628722
|
| 4 |
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018). Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
|
| 5 |
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chemico-Biological Interactions 2025; 421: 111784 doi: 10.1016/j.cbi.2025.111784
|
| 6 |
Jiahui Li, Lijia Diao, Menglin Li, Fugang Huang, Ke Sun. Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1642377
|
| 7 |
Haiyan Jiang, Xiaoran Wang, Wei Zhou, Zhili Huang, Wen Zhang. Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1661037
|
| 8 |
Jin Rong, Yuanhua Dai, Bo Zhang, Yuxi Li, Kexu Chen, Hanfei Li, Tingting Zhao, Shunmei Liu. Diabetic kidney disease and aging: Focus on gut microbiota. Life Sciences 2025; 381: 123999 doi: 10.1016/j.lfs.2025.123999
|
| 9 |
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design, Development and Therapy 2025; : 9457 doi: 10.2147/DDDT.S557114
|
| 10 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 11 |
Qianwei Wang, Yucheng Han, Liang Pang, Zhicheng Zhou, Lijuan Dai. Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1620247
|
| 12 |
Ziyi Li, Shi Yang, Xinyi Zhou, Yan Qing, Tiyan Zhang, Wenliu Xu, Wei Duan, Fajian Ren, Hua Deng, Wenjing Wang, Ming Li, Min Feng, Chaolong Rao. Alterations in gut–kidney axis indicators and TMAO-related biomarkers in elderly patients with hypertensive nephropathy. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1671036
|